These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 15852026

  • 1. Unexpected immune complications in patients with non-Hodgkin's lymphoma receiving CD34-selected autologous peripheral stem cell transplantation.
    Cordoba R, Arranz R, Cannata J.
    Bone Marrow Transplant; 2005 Jun; 35(12):1217-8. PubMed ID: 15852026
    [No Abstract] [Full Text] [Related]

  • 2. [Effect of growth factor on the phenotype of subpopulations and on the kinetics of CD34+ cells in the peripheral blood and in grafts of peripheral stem cells in patients with non-Hodgkin's lymphoma indicated for autologous peripheral blood stem cell transplantation].
    Klabusay M, Lysák D, Hrabcáková V, Navrátil M, Coupek P, Mayer J.
    Cas Lek Cesk; 2008 Jun; 147(6):319-24. PubMed ID: 18724529
    [Abstract] [Full Text] [Related]

  • 3. Evans' syndrome following autologous peripheral blood stem cell transplantation for non-Hodgkin's lymphoma.
    Kamezaki K, Fukuda T, Makino S, Harada M.
    Clin Lab Haematol; 2004 Aug; 26(4):291-3. PubMed ID: 15279667
    [Abstract] [Full Text] [Related]

  • 4. Efficacy of single dose pegfilgrastim in enhancing the mobilization of CD34+ peripheral blood stem cells in aggressive lymphoma patients treated with cisplatin-aracytin-containing regimens.
    Nosari A, Cairoli R, Ciapanna D, Gargantini L, Intropido L, Baraté C, Scarpati B, Santoleri L, Nador G, Pezzetti L, Morra E.
    Bone Marrow Transplant; 2006 Sep; 38(6):413-6. PubMed ID: 16878144
    [Abstract] [Full Text] [Related]

  • 5. Peripheral blood progenitor cell collection without close monitoring of peripheral blood CD34+ cells: A feasible strategy for multiple myeloma or pre-treated Non-Hodgkin's Lymphoma patients mobilized with low-dose cyclophosphamide plus G-CSF.
    Callera F, Cavenaghi L, de Melo CM.
    Transfus Apher Sci; 2009 Apr; 40(2):91-5. PubMed ID: 19233728
    [Abstract] [Full Text] [Related]

  • 6. Peripheral blood hematopoietic stem cell mobilization and collection efficacy is not an independent prognostic factor for autologous stem cell transplantation.
    Wang S, Nademanee A, Qian D, Dagis A, Park HS, Fridey J, Smith E, Snyder D, Somlo G, Stein A, Rosenthal J, Falk P, Kogut N, Palmer J, Gaal K, Kim Y, Bhatia R, Yuan S, Kay C, Weiss L, Forman S.
    Transfusion; 2007 Dec; 47(12):2207-16. PubMed ID: 17714420
    [Abstract] [Full Text] [Related]

  • 7. Isolation and transplantation of highly purified autologous peripheral CD34+ progenitor cells: purging efficacy, hematopoietic reconstitution in non-Hodgkin's lymphoma (NHL): results of Japanese phase II study.
    Imai Y, Chou T, Tobinai K, Tanosaki R, Morishima Y, Ogura M, Shimazaki C, Taniwaki M, Hiraoka A, Tanimoto M, Koike T, Kogawa K, Hirai H, Yoshida T, Tamura K, Kishi K, Hotta T, CliniMACS Study Group.
    Bone Marrow Transplant; 2005 Mar; 35(5):479-87. PubMed ID: 15654349
    [Abstract] [Full Text] [Related]

  • 8. Development of rheumatoid arthritis following autologous peripheral blood stem cell transplantation.
    Imamura R, Inoue H, Kato K, Kobayashi S, Tsukamoto H, Nagafuji K, Shimoda K, Nakashima H, Otsuka T, Gondo H, Harada M.
    Bone Marrow Transplant; 2002 Oct; 30(8):527-9. PubMed ID: 12379893
    [Abstract] [Full Text] [Related]

  • 9. Immunological reconstitution after autologous peripheral blood stem cell transplantation in patients with chronic lymphocytic leukemia. Comparison with an historical non-Hodgkin's lymphoma group.
    Laurenti L, Piccirillo N, Sorà F, Piccioni P, Tarnani M, Leone G, Sica S.
    Haematologica; 2004 Jan; 89(1):120-2. PubMed ID: 14754622
    [No Abstract] [Full Text] [Related]

  • 10. Autologous stem cell transplantation with selected CD34+ cells and unmanipulated peripheral blood stem cells in patients with relapsed and refractory Hodgkin's lymphoma: a single centre experience.
    Ballova V, Ladicka M, Vranovsky A, Lakota J.
    Neoplasma; 2008 Jan; 55(5):428-36. PubMed ID: 18665754
    [Abstract] [Full Text] [Related]

  • 11. CD34(+) hematopoietic progenitor cell selection of bone marrow grafts for autologous transplantation in pediatric patients.
    Kasow KA, Sims-Poston L, Eldridge P, Hale GA.
    Biol Blood Marrow Transplant; 2007 May; 13(5):608-14. PubMed ID: 17448921
    [Abstract] [Full Text] [Related]

  • 12. Isolation of purified autologous peripheral blood CD34+ cells with low T cell content using CliniMACS device--a local experience.
    Leong CF, Habsah A, Teh HS, Goh KY, Fadilah SA, Cheong SK.
    Malays J Pathol; 2008 Jun; 30(1):31-6. PubMed ID: 19108409
    [Abstract] [Full Text] [Related]

  • 13. Long-term follow-up of patients with non-Hodgkin lymphoma following myeloablative therapy and autologous transplantation of CD34+-selected peripheral blood progenitor cells.
    Witzens-Harig M, Heilmann C, Hensel M, Kornacker M, Benner A, Haas R, Fruehauf S, Ho AD.
    Stem Cells; 2007 Jan; 25(1):228-35. PubMed ID: 17204607
    [Abstract] [Full Text] [Related]

  • 14. [Clinical observation of selected CD34(+) cell autologous transplantation in non-Hodgin lymphoma: report of 5 cases].
    You Y, Xia LH, Zhang C, Liu F, Chen ZC, Zou P.
    Zhonghua Yi Xue Za Zhi; 2007 Nov 27; 87(44):3127-9. PubMed ID: 18269872
    [Abstract] [Full Text] [Related]

  • 15. Hematopoietic abnormalities persist for more than six years after autologous peripheral blood stem cell transplantation in patients with non-Hodgkin's lymphoma.
    López-Holgado N, Garzòn S, Martín A, Hermosín L, Campos R, León A.
    Haematologica; 2004 Jan 27; 89(1):122-4. PubMed ID: 14754623
    [No Abstract] [Full Text] [Related]

  • 16. A preliminary analysis of the balance between Th1 and Th2 cells after CD34+ cell-selected autologous PBSC transplantation.
    Endo T, Sato N, Koizumi K, Nishio M, Fujimoto K, Yamamoto S, Sakai T, Bohgaki T, Sawada K, Koike T.
    Cytotherapy; 2004 Jan 27; 6(4):337-43. PubMed ID: 16146886
    [Abstract] [Full Text] [Related]

  • 17. Autologous peripheral blood stem cell transplantation in children with non-Hodgkin's lymphoma: A report from the Korean society of pediatric hematology-oncology.
    Won SC, Han JW, Kwon SY, Shin HY, Ahn HS, Hwang TJ, Yang WI, Lyu CJ.
    Ann Hematol; 2006 Nov 27; 85(11):787-94. PubMed ID: 16932891
    [Abstract] [Full Text] [Related]

  • 18. Linear IgA bullous dermatosis following autologous PBSC transplantation in a patient with non-Hodgkin's lymphoma.
    Yhim HY, Kwon DH, Lee NR, Song EK, Yim CY, Kwak JY.
    Bone Marrow Transplant; 2011 Jan 27; 46(1):156-8. PubMed ID: 20383218
    [No Abstract] [Full Text] [Related]

  • 19. Cyclophosphamide, etoposide and carboplatine plus non-cryopreserved autologous peripheral blood stem cell transplantation rescue for patients with refractory or relapsed non-Hodgkin's lymphomas.
    Mabed M, Al-Kgodary T.
    Bone Marrow Transplant; 2006 Apr 27; 37(8):739-43. PubMed ID: 16501587
    [Abstract] [Full Text] [Related]

  • 20. Higher infused CD34+ hematopoietic stem cell dose correlates with earlier lymphocyte recovery and better clinical outcome after autologous stem cell transplantation in non-Hodgkin's lymphoma.
    Yoon DH, Sohn BS, Jang G, Kim EK, Kang BW, Kim C, Kim JE, Kim S, Lee DH, Lee JS, Park SJ, Park CJ, Huh J, Suh C.
    Transfusion; 2009 Sep 27; 49(9):1890-900. PubMed ID: 19453991
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.